- Home
- VRNT vs BCYC Comparison
VRNT vs BCYC Comparison
Compare VRNT & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNT
- BCYC
- Stock Information
- Founded
- VRNT 1994
- BCYC 2009
- Country
- VRNT United States
- BCYC United Kingdom
- Employees
- VRNT N/A
- BCYC N/A
- Industry
- VRNT EDP Services
- BCYC Biotechnology: Pharmaceutical Preparations
- Sector
- VRNT Technology
- BCYC Health Care
- Exchange
- VRNT Nasdaq
- BCYC Nasdaq
- Market Cap
- VRNT 1.5B
- BCYC 1.7B
- IPO Year
- VRNT N/A
- BCYC 2019
- Fundamental
- Price
- VRNT $24.72
- BCYC $13.56
- Analyst Decision
- VRNT Buy
- BCYC Buy
- Analyst Count
- VRNT 7
- BCYC 9
- Target Price
- VRNT $35.67
- BCYC $34.50
- AVG Volume (30 Days)
- VRNT 721.4K
- BCYC 417.9K
- Earning Date
- VRNT 12-04-2024
- BCYC 02-18-2025
- Dividend Yield
- VRNT N/A
- BCYC N/A
- EPS Growth
- VRNT 2980.37
- BCYC N/A
- EPS
- VRNT 0.95
- BCYC N/A
- Revenue
- VRNT $920,749,000.00
- BCYC $36,898,000.00
- Revenue This Year
- VRNT $4.50
- BCYC $40.69
- Revenue Next Year
- VRNT $4.45
- BCYC N/A
- P/E Ratio
- VRNT $25.60
- BCYC N/A
- Revenue Growth
- VRNT 4.45
- BCYC 48.60
- 52 Week Low
- VRNT $21.28
- BCYC $12.17
- 52 Week High
- VRNT $38.17
- BCYC $28.67
- Technical
- Relative Strength Index (RSI)
- VRNT 39.98
- BCYC 36.71
- Support Level
- VRNT $24.19
- BCYC $13.20
- Resistance Level
- VRNT $26.64
- BCYC $15.43
- Average True Range (ATR)
- VRNT 0.95
- BCYC 0.88
- MACD
- VRNT -0.28
- BCYC 0.15
- Stochastic Oscillator
- VRNT 13.84
- BCYC 15.86
About VRNT Verint Systems Inc.
Verint Systems Inc with its subsidiaries helps brands provide Boundless Customer Engagement. The company's solutions help iconic brands close the gap created when it lacks the resources required to deliver experiences that fulfill customer expectations. Geographically, it derives a majority of its revenue from the United States.
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.